Alpha-9 Oncology
Vancouver
About Alpha-9 Oncology
Alpha-9 Oncology is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $259.0M
- Funding stage: Late Stage Venture
- Last round: Series C (Oct 2024)
- Website: a9oncology.com
- Phone: 778-231-2500
Industries & Categories
Biotechnology, Medical, Product Research
Social Profiles
Canonical: https://fsome.com/organization/alpha-9-oncology-56189 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.